Literature DB >> 8224613

Retinoblastoma and p53 tumor suppressor genes in human hepatoma cell lines.

A Puisieux1, K Galvin, F Troalen, B Bressac, C Marcais, E Galun, F Ponchel, C Yakicier, J Ji, M Ozturk.   

Abstract

We analyzed the status of retinoblastoma and p53 genes in 10 human hepatoma cell lines. Polyclonal anti-peptide antibodies generated against peptides homologous to COOH-terminal and leucine-zipper domains of the retinoblastoma protein allowed us to identify two cell lines (Hep 3B and FOCUS) with abnormal expression. The same cell lines have both lacked p53 expression. In contrast to the retinoblastoma gene, the expression of the p53 gene was abnormal in six additional cell lines. Indeed, only the Hep G2 hepatoblastoma cell line (and its derivative Hep G2/2215) appeared to have normal p53 and retinoblastoma gene expression. Our studies indicate that p53 abnormalities are common but retinoblastoma gene aberrations are rare in human hepatoma cell lines.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8224613     DOI: 10.1096/fasebj.7.14.8224613

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  32 in total

1.  Apicidin-resistant HA22T hepatocellular carcinoma cells massively promote pro-survival capability via IGF-IR/PI3K/Akt signaling pathway activation.

Authors:  Hsi-Hsien Hsu; Li-Hao Cheng; Tsung-Jung Ho; Wei-Wen Kuo; Yueh-Min Lin; Ming-Cheng Chen; Nien-Hung Lee; Fuu-Jen Tsai; Kun-Hsi Tsai; Chih-Yang Huang
Journal:  Tumour Biol       Date:  2013-08-30

2.  Transcriptional targeting of herpes simplex virus for cell-specific replication.

Authors:  S Miyatake; A Iyer; R L Martuza; S D Rabkin
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

3.  Safety-modified episomal vectors for human gene therapy.

Authors:  M J Cooper; M Lippa; J M Payne; G Hatzivassiliou; E Reifenberg; B Fayazi; J C Perales; L J Morrison; D Templeton; R L Piekarz; J Tan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

4.  Distinct regulation of p53 and p73 activity by adenovirus E1A, E1B, and E4orf6 proteins.

Authors:  W T Steegenga; A Shvarts; N Riteco; J L Bos; A G Jochemsen
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

5.  Tumor suppressor protein p53 negatively regulates human pregnane X receptor activity.

Authors:  Ayesha Elias; Jing Wu; Taosheng Chen
Journal:  Mol Pharmacol       Date:  2013-03-27       Impact factor: 4.436

6.  Targeted p21WAF1/CIP1 activation by RNAa inhibits hepatocellular carcinoma cells.

Authors:  Mika Kosaka; Moo Rim Kang; Glen Yang; Long-Cheng Li
Journal:  Nucleic Acid Ther       Date:  2012-08-21       Impact factor: 5.486

7.  The tumor suppressor protein p53 strongly alters human immunodeficiency virus type 1 replication.

Authors:  L Duan; I Ozaki; J W Oakes; J P Taylor; K Khalili; R J Pomerantz
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

8.  Arecoline induces HA22T/VGH hepatoma cells to undergo anoikis - involvement of STAT3 and RhoA activation.

Authors:  Hsiao-Ling Cheng; Shu-Jem Su; Li-Wen Huang; Bau-Shan Hsieh; Yu-Chen Hu; Thu-Ching Hung; Kee-Lung Chang
Journal:  Mol Cancer       Date:  2010-05-28       Impact factor: 27.401

9.  Insulin-like growth factor-binding protein-7 (IGFBP7): a promising gene therapeutic for hepatocellular carcinoma (HCC).

Authors:  Dong Chen; Ayesha Siddiq; Luni Emdad; Devaraja Rajasekaran; Rachel Gredler; Xue-Ning Shen; Prasanna K Santhekadur; Jyoti Srivastava; Chadia L Robertson; Igor Dmitriev; Elena A Kashentseva; David T Curiel; Paul B Fisher; Devanand Sarkar
Journal:  Mol Ther       Date:  2013-01-15       Impact factor: 11.454

10.  Commitment to apoptosis by ceramides depends on mitochondrial respiratory function, cytochrome c release and caspase-3 activation in Hep-G2 cells.

Authors:  Benoit Gentil; Fabrice Grimot; Catherine Riva
Journal:  Mol Cell Biochem       Date:  2003-12       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.